Aureus Asset Management’s Novo Nordisk NVO Stock Holding History

Aureus Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Hold	27,220	–	–	0.08%	109
2026 Q1	$1M	Sell	27,220 -2,084	-7%	-$98.7K	0.07%	112
2025 Q4	$1.49M	Sell	29,304 -433	-1%	-$22.1K	0.1%	83
2025 Q3	$1.65M	Buy	29,737 +23,861	+406%	+$1.4M	0.11%	74
2025 Q2	$406K	Buy	+5,876	New	+$400K	0.03%	139
2025 Q1	–	Sell	-2,394	Closed	-$206K	–	213
2024 Q4	$206K	Hold	2,394	–	–	0.01%	203
2024 Q3	$285K	Sell	2,394 -81	-3%	-$10.8K	0.02%	161
2024 Q2	$353K	Hold	2,475	–	–	0.02%	144
2024 Q1	$318K	Hold	2,475	–	–	0.02%	153
2023 Q4	$256K	Hold	2,475	–	–	0.02%	161
2023 Q3	$225K	Sell	2,475 -177	-7%	-$15.6K	0.02%	169
2023 Q2	$215K	Hold	2,652	–	–	0.02%	164
2023 Q1	$211K	Buy	+2,652	New	+$188K	0.02%	170

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aureus Asset Management's NVO Position: Q2 2026 in Review

Aureus Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 27,220 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #109.

Aureus Asset Management first reported a position in NVO in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.65M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Aureus Asset Management held 27,220 shares of Novo Nordisk worth $1.3M as of Q2 2026.
Aureus Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.08% of Aureus Asset Management's portfolio in Q2 2026, its #109 holding.
Aureus Asset Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 13 quarters since.
Aureus Asset Management's Novo Nordisk position peaked at $1.65M in Q3 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.